Isabelle Hatin

Isabelle Hatin

Auto-generated profile, based on publicly available information

Isabelle Hatin

Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2001 in EMBO Reports
Verified
Journal Article
Open access
PDF file
ONOlivier Namy
Olivier Namy
IHIsabelle Hatin
Isabelle Hatin
JRJean‐Pierre Rousset
Jean‐Pierre Rousset
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

29 March 2012 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
CFCélia Floquet
Célia Floquet
IHIsabelle Hatin
Isabelle Hatin
JRJean-Pierre Rousset
Jean-Pierre Rousset
LBLaure Bidou
Laure Bidou
The efficiency of translation termination depends on the nature of the stop codon and the surrounding nucleotides. Some molecules, such as aminoglycoside antibiotics (gentamicin), decrease termination efficiency and are currently being evaluated for diseases caused by premature termination codons. However, the readthrough response to treatment is highly variable and little is known about the rules governing readthrough level and response to aminoglycosides. In this study, we carried out in-depth statistical analysis on a very large set of nonsense mutations to decipher the elements of nucleotide context responsible for modulating readthrough levels and gentamicin response. We quantified readthrough for 66 sequences containing a stop codon, in the presence and absence of gentamicin, in cultured mammalian cells. We demonstrated that the efficiency of readthrough after treatment is determined by the complex interplay between the stop codon and a larger sequence context. There was a strong positive correlation between basal and induced readthrough levels, and a weak negative correlation between basal readthrough level and gentamicin response (i.e. the factor of increase from basal to induced readthrough levels). The identity of the stop codon did not affect the response to gentamicin treatment. In agreement with a previous report, we confirm that the presence of a cytosine in +4 position promotes higher basal and gentamicin-induced readthrough than other nucleotides. We highlight for the first time that the presence of a uracil residue immediately upstream from the stop codon is a major determinant of the response to gentamicin. Moreover, this effect was mediated by the nucleotide itself, rather than by the amino-acid or tRNA corresponding to the −1 codon. Finally, we point out that a uracil at this position associated with a cytosine at +4 results in an optimal gentamicin-induced readthrough, which is the therapeutically relevant variable. Nonsense mutations are single-nucleotide variations within the coding sequence of a gene that result in a premature termination codon. The presence of such mutations leads to the synthesis of a truncated protein unable to fulfill its normal function. Over the last ten years, treatment strategies have emerged based on the use of molecules, such as aminoglycoside antibiotics (gentamicin) that facilitate the readthrough of premature termination codons, thus restoring the synthesis of a full-length protein. Such strategies have been tested for various genetic diseases, including Duchenne muscular dystrophy and cystic fibrosis. The readthrough level depends on the nature of the stop codon and the surrounding nucleotide context, but little was known of the rules governing readthrough level and response to aminoglycosides. In this study, we use a large set of nonsense mutations for an in-depth statistical analysis designed to decipher the element of the nucleotide context responsible for modulating readthrough levels. We analyse the impact of the six nucleotides upstream and downstream from the stop codon. We demonstrate that the presence of a uracil residue immediately upstream the stop codon is associated with a stronger response to gentamicin treatment than the presence of any of the other three nucleotides.

19 February 2004 in Gene Therapy
Verified
Journal Article
Closed access
LBL Bidou
L Bidou
IHI Hatin
I Hatin
NPN Perez
N Perez
VAV Allamand
V Allamand
JPJ-J Panthier
J-J Panthier
JRJ-P Rousset
J-P Rousset

1 February 2011 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
BYBasma El Yacoubi
Basma El Yacoubi
IHIsabelle Hatin
Isabelle Hatin
CDChristopher Deutsch
Christopher Deutsch
TKTamer Kahveci
Tamer Kahveci
JRJean‐Pierre Rousset
Jean‐Pierre Rousset
VCValerie De Crecy-Lagard
Valerie De Crecy-Lagard
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 May 2003 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ONOlivier Namy
Olivier Namy
GDGuillemette Duchateau‐Nguyen
Guillemette Duchateau‐Nguyen
IHIsabelle Hatin
Isabelle Hatin
SDSylvie Hermann‐Le Denmat
Sylvie Hermann‐Le Denmat
MTMichel Termier
Michel Termier
JRJean‐Pierre Rousset
Jean‐Pierre Rousset
We specifically sought genes within the yeast genome controlled by a non‐conventional translation mechanism involving the stop codon. For this reason, we designed a computer program using the yeast database genomic regions, and seeking two adjacent open reading frames separated only by a unique stop codon (called SORFs). Among the 58 SORFs identified, eight displayed a stop codon bypass level ranging from 3 to 25%. For each of the eight sequences, we demonstrated the presence of a poly(A) mRNA. Using isogenic [PSI+] and [psi–] yeast strains, we showed that for two of the sequences the mechanism used is a bona fide readthrough. However, the six remaining sequences were not sensitive to the PSI state, indicating either a translation termination process independent of eRF3 or a new stop codon bypass mechanism. Our results demonstrate that the presence of a stop codon in a large ORF may not always correspond to a sequencing error, or a pseudogene, but can be a recoding signal in a functional gene. This emphasizes that genome annotation should take into account the fact that recoding signals could be more frequently used than previously expected.

4 January 2016 in Microbial Cell
Verified
Journal Article
Open access
PTPatrick C. Thiaville
Patrick C. Thiaville
RLRachel Legendre
Rachel Legendre
DRDiego Rojas-Benitez
Diego Rojas-Benitez
ABAgnes Baudin-Baillieu
Agnes Baudin-Baillieu
IHIsabelle Hatin
Isabelle Hatin
VCValerie De Crecy-Lagard
Valerie De Crecy-Lagard
Global translational impacts of the loss of the tRNA modification t6A in yeast –